Lenox Wealth Advisors’s Bio-Techne TECH Stock Holding History

Lenox Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$65K	Hold	600	–	–	0.01%	220
2021 Q4	$78K	Hold	600	–	–	0.01%	199
2021 Q3	$73K	Hold	600	–	–	0.01%	187
2021 Q2	$68K	Hold	600	–	–	0.01%	191
2021 Q1	$57K	Hold	600	–	–	0.01%	177
2020 Q4	$48K	Hold	600	–	–	0.01%	188
2020 Q3	$37K	Hold	600	–	–	0.01%	197
2020 Q2	$40K	Hold	600	–	–	0.01%	186
2020 Q1	$28K	Hold	600	–	–	0.01%	211
2019 Q4	$33K	Buy	+600	New	+$31.5K	0.01%	240

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Lenox Wealth Advisors's TECH Position: Q1 2022 in Review

Lenox Wealth Advisors held its Bio-Techne (TECH) position steady in Q1 2022 at 600 shares worth $65K. The position accounts for 0.01% of the portfolio, ranked #220.

Lenox Wealth Advisors first reported a position in TECH in Q4 2019 and has held it in 10 quarters since. The position peaked at $78K in Q4 2021. 556 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

Lenox Wealth Advisors held 600 shares of Bio-Techne worth $65K as of Q1 2022.
Lenox Wealth Advisors left its Bio-Techne share count unchanged in Q1 2022.
Bio-Techne made up 0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #220 holding.
Lenox Wealth Advisors first reported a position in Bio-Techne in Q4 2019 and has held it in 10 quarters since.
Lenox Wealth Advisors's Bio-Techne position peaked at $78K in Q4 2021.
556 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.